Raydiant Oximetry
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Raydiant Oximetry sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Raydiant Oximetry: 7 sponsored US clinical trials, 1 recruiting.
Raydiant Oximetry sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Fetal Acidemia, with 1 trials.
Upper-quartile sponsor footprint
Raydiant Oximetry sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems
NCT07296419
DAISY Uterine Drain Device Evaluation
NCT06219538
Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE
NCT06405984
Trans-abdominal Fetal Pulse Oximetry
NCT05147584
Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity
NCT04876846
Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering
NCT04081584
Trans-abdominal Fetal Pulse Oximetry: Signal Integrity
NCT04081623
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Therapeutic Areas
What is open in the Raydiant Oximetry pipeline
1 recruiting of 7 indexed (14% open); 3 completed (43%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Fetal Acidemia (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Raydiant Oximetry: open-pipeline peers nationwide
Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Raydiant Oximetry sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Raydiant Oximetry page
7 registered trials is a research-attention snapshot, not an endorsement of Raydiant Oximetry or any single study.
- 1 of Raydiant Oximetry's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Fetal Acidemia is the condition Raydiant Oximetry studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Fetal Acidemia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Raydiant Oximetry pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.